PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8298870

What is the nephrogram?

P Dawson·A M Peters
View original source ↗Export metadata ↓

Abstract

One of the oldest questions in radiology, "what is the nephrogram?", has been approached in a novel manner using dynamic bolus contrast enhanced computed tomography to monitor the arrival and distribution of contrast agent in the normal kidney. A modification of a mathematical technique first developed for applications in positron emission tomography has been used to analyse the data. It is concluded that the blood pool contribution to the nephrogram is greater in the first minutes after rapid bolus contrast injection than generally supposed and that the "immediate" nephrogram is a predominantly blood pool contrast phenomenon.

Explore related subjects

Aorta, AbdominalContrast MediaFemaleHumansKidneyModels, BiologicalTomography, X-Ray ComputedJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Dawson, A M Peters. 1994. What is the nephrogram?. https://doi.org/10.1259/0007-1285-67-793-21

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Macrophage products inhibit human aortic smooth muscle cell proliferation and alter 1 alpha (I) procollagen expression.

While the role of the foam cell in early atherogenesis has been well characterized, much less is known about the interaction between infiltrating macrophages and medial smooth muscle cells (SMC) in chronic atherosclerosis. Our purpose was to determine the effects of soluble macrophage mediators on normal human aortic SMC proliferation and matrix expression. Human aortic SMC in subconfluent culture were exposed to supernatants from activated lipopolysaccharide (LPS) and nonactivated macrophages. SMC proliferation and type-I procollagen expression were determined. Both activated and nonactivated macrophage supernatants exhibited a potent growth inhibitory effect which became apparent at 48 hours. While nonactivated macrophage supernatant had no effect on procollagen expression, activated supernatant inhibited its expression. (33%; p < 0.05) These findings are consistent with the loss of medial SMC and matrix proteins associated with chronic atherosclerosis.

Aorta, Abdominal↗
PubMed1997

Enhancement of hepatic parenchyma, aorta, and portal vein in helical CT: comparison of iodixanol and iopromide.

OBJECTIVE: The purpose of this study was to determine hepatic, aortic, and portal vein enhancement with a new dimeric, nonionic, isotonic contrast medium (iodixanol) in a routinely performed helical CT protocol and compare enhancement characteristics with those of a monomeric, nonionic, low-osmolality contrast medium (iopromide). SUBJECTS AND METHODS: In 81 patients, we injected 150 ml of iodixanol (320 mg I/ml), iodixanol (300 mg I/ml), or iopromide (300 mg I/ml). Injection rate was 5 ml/sec. A dual-phase helical CT scan was obtained (first helical scan began at 30 sec. second helical scan began at 70 sec), and enhancement characteristics were assessed. Results were analyzed taking into account various intrinsic parameters of patients. RESULTS: During the second imaging phase, iodixanol at 320 mg I/ml and iodixanol at 300 mg I/ml provided significantly higher enhancement of the liver (75 H, 69 H, 62 H), aorta (144 H, 140 H, 122 H), and portal vein (147 H, 147 H, 118 H) than did iopromide at 300 mg I/ml. No significant differences were observed during the first imaging phase. CONCLUSION: The combination of higher vascular and parenchymal enhancement levels after injection of the isotonic agent may represent a different quality of tissue enhancement. Such an enhancement would be characterized more by a higher contribution of the blood pool compartment to absolute enhancement levels than by a contribution of the interstitial compartment. Further studies are needed to determine whether the use of isotonic agents effects lesion conspicuity.

Aorta, Abdominal↗